Literature DB >> 24812208

The cellular and molecular origin of tumor-associated macrophages.

Ruth A Franklin1, Will Liao2, Abira Sarkar3, Myoungjoo V Kim1, Michael R Bivona3, Kang Liu4, Eric G Pamer3, Ming O Li5.   

Abstract

Long recognized as an evolutionarily ancient cell type involved in tissue homeostasis and immune defense against pathogens, macrophages are being rediscovered as regulators of several diseases, including cancer. Here we show that in mice, mammary tumor growth induces the accumulation of tumor-associated macrophages (TAMs) that are phenotypically and functionally distinct from mammary tissue macrophages (MTMs). TAMs express the adhesion molecule Vcam1 and proliferate upon their differentiation from inflammatory monocytes, but do not exhibit an "alternatively activated" phenotype. TAM terminal differentiation depends on the transcriptional regulator of Notch signaling, RBPJ; and TAM, but not MTM, depletion restores tumor-infiltrating cytotoxic T cell responses and suppresses tumor growth. These findings reveal the ontogeny of TAMs and a discrete tumor-elicited inflammatory response, which may provide new opportunities for cancer immunotherapy.
Copyright © 2014, American Association for the Advancement of Science.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24812208      PMCID: PMC4204732          DOI: 10.1126/science.1252510

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  32 in total

1.  Summaries of Affymetrix GeneChip probe level data.

Authors:  Rafael A Irizarry; Benjamin M Bolstad; Francois Collin; Leslie M Cope; Bridget Hobbs; Terence P Speed
Journal:  Nucleic Acids Res       Date:  2003-02-15       Impact factor: 16.971

2.  Minimal differentiation of classical monocytes as they survey steady-state tissues and transport antigen to lymph nodes.

Authors:  Claudia Jakubzick; Emmanuel L Gautier; Sophie L Gibbings; Dorothy K Sojka; Andreas Schlitzer; Theodore E Johnson; Stoyan Ivanov; Qiaonan Duan; Shashi Bala; Tracy Condon; Nico van Rooijen; John R Grainger; Yasmine Belkaid; Avi Ma'ayan; David W H Riches; Wayne M Yokoyama; Florent Ginhoux; Peter M Henson; Gwendalyn J Randolph
Journal:  Immunity       Date:  2013-09-05       Impact factor: 31.745

3.  Mice lacking flt3 ligand have deficient hematopoiesis affecting hematopoietic progenitor cells, dendritic cells, and natural killer cells.

Authors:  H J McKenna; K L Stocking; R E Miller; K Brasel; T De Smedt; E Maraskovsky; C R Maliszewski; D H Lynch; J Smith; B Pulendran; E R Roux; M Teepe; S D Lyman; J J Peschon
Journal:  Blood       Date:  2000-06-01       Impact factor: 22.113

Review 4.  Regulation of innate and adaptive immunity by Notch.

Authors:  Freddy Radtke; H Robson MacDonald; Fabienne Tacchini-Cottier
Journal:  Nat Rev Immunol       Date:  2013-05-13       Impact factor: 53.106

Review 5.  Macrophage biology in development, homeostasis and disease.

Authors:  Thomas A Wynn; Ajay Chawla; Jeffrey W Pollard
Journal:  Nature       Date:  2013-04-25       Impact factor: 49.962

6.  Monocyte emigration from bone marrow during bacterial infection requires signals mediated by chemokine receptor CCR2.

Authors:  Natalya V Serbina; Eric G Pamer
Journal:  Nat Immunol       Date:  2006-02-05       Impact factor: 25.606

7.  Induction of mammary tumors by expression of polyomavirus middle T oncogene: a transgenic mouse model for metastatic disease.

Authors:  C T Guy; R D Cardiff; W J Muller
Journal:  Mol Cell Biol       Date:  1992-03       Impact factor: 4.272

8.  Postnatal mammary gland development requires macrophages and eosinophils.

Authors:  V Gouon-Evans; M E Rothenberg; J W Pollard
Journal:  Development       Date:  2000-06       Impact factor: 6.868

9.  Colony-stimulating factor 1 promotes progression of mammary tumors to malignancy.

Authors:  E Y Lin; A V Nguyen; R G Russell; J W Pollard
Journal:  J Exp Med       Date:  2001-03-19       Impact factor: 14.307

10.  Notch2-dependent classical dendritic cells orchestrate intestinal immunity to attaching-and-effacing bacterial pathogens.

Authors:  Ansuman T Satpathy; Carlos G Briseño; Jacob S Lee; Dennis Ng; Nicholas A Manieri; Wumesh Kc; Xiaodi Wu; Stephanie R Thomas; Wan-Ling Lee; Mustafa Turkoz; Keely G McDonald; Matthew M Meredith; Christina Song; Cynthia J Guidos; Rodney D Newberry; Wenjun Ouyang; Theresa L Murphy; Thaddeus S Stappenbeck; Jennifer L Gommerman; Michel C Nussenzweig; Marco Colonna; Raphael Kopan; Kenneth M Murphy
Journal:  Nat Immunol       Date:  2013-08-04       Impact factor: 25.606

View more
  497 in total

1.  Improved Multiplex Immunohistochemistry for Immune Microenvironment Evaluation of Mouse Formalin-Fixed, Paraffin-Embedded Tissues.

Authors:  Noah Sorrelle; Debolina Ganguly; Adrian T A Dominguez; Yuqing Zhang; Huocong Huang; Lekh N Dahal; Natalie Burton; Arturas Ziemys; Rolf A Brekken
Journal:  J Immunol       Date:  2018-12-03       Impact factor: 5.422

Review 2.  Lipid Metabolism in Tumor-Associated Macrophages.

Authors:  Yuancai Xiang; Hongming Miao
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

3.  Acute myeloid leukemia cells polarize macrophages towards a leukemia supporting state in a Growth factor independence 1 dependent manner.

Authors:  Yahya S Al-Matary; Lacramioara Botezatu; Bertram Opalka; Judith M Hönes; Robert F Lams; Aniththa Thivakaran; Judith Schütte; Renata Köster; Klaus Lennartz; Thomas Schroeder; Rainer Haas; Ulrich Dührsen; Cyrus Khandanpour
Journal:  Haematologica       Date:  2016-07-07       Impact factor: 9.941

4.  Cyclooxygenase and lipoxygenase gene expression in the inflammogenesis of breast cancer.

Authors:  Brian M Kennedy; Randall E Harris
Journal:  Inflammopharmacology       Date:  2018-05-07       Impact factor: 4.473

5.  Absence of host NF-κB p50 induces murine glioblastoma tumor regression, increases survival, and decreases T-cell induction of tumor-associated macrophage M2 polarization.

Authors:  Theresa Barberi; Allison Martin; Rahul Suresh; David J Barakat; Sarah Harris-Bookman; Charles G Drake; Michael Lim; Alan D Friedman
Journal:  Cancer Immunol Immunother       Date:  2018-07-21       Impact factor: 6.968

Review 6.  Plasticity of myeloid-derived suppressor cells in cancer.

Authors:  Evgenii Tcyganov; Jerome Mastio; Eric Chen; Dmitry I Gabrilovich
Journal:  Curr Opin Immunol       Date:  2018-03-14       Impact factor: 7.486

7.  Iron oxide nanoparticles inhibit tumour growth by inducing pro-inflammatory macrophage polarization in tumour tissues.

Authors:  Saeid Zanganeh; Gregor Hutter; Ryan Spitler; Olga Lenkov; Morteza Mahmoudi; Aubie Shaw; Jukka Sakari Pajarinen; Hossein Nejadnik; Stuart Goodman; Michael Moseley; Lisa Marie Coussens; Heike Elisabeth Daldrup-Link
Journal:  Nat Nanotechnol       Date:  2016-09-26       Impact factor: 39.213

8.  Hepatic Stellate Cell-Macrophage Crosstalk in Liver Fibrosis and Carcinogenesis.

Authors:  Michitaka Matsuda; Ekihiro Seki
Journal:  Semin Liver Dis       Date:  2020-04-02       Impact factor: 6.115

9.  Ovarian Cancer: Therapeutic Strategies to Overcome Immune Suppression.

Authors:  Maureen L Drakes; Patrick J Stiff
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

Review 10.  Epigenetic mechanisms of tumor resistance to immunotherapy.

Authors:  Natalia Arenas-Ramirez; Dilara Sahin; Onur Boyman
Journal:  Cell Mol Life Sci       Date:  2018-08-23       Impact factor: 9.261

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.